Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Gubra ApS & Bayer Partner to Develop Cardiorenal Treatments (2021-09-20)
> Gubra ApS announced today a new research collaboration and license agreement with Bayer AG for the development of novel peptide therapeutics to treat cardiorenal disease. > Cardiorenal disease is an umbrella term for acute and chronic disorders, involving both...
Novo Commits $47.5m to New Research Center at Broad (2021-09-15)
Supported by a $47.5 million commitment from the Foundation, the Center will facilitate close collaborations between the Broad Institute and Danish researchers investigating the genetics and gene regulation of common complex disease, with an initial focus on type 2...
Nordic Nanovector Appoints Erik Skullerud as CEO (2021-09-14)
Nordic Nanovector ASA (OSE: NANOV) announces the appointment of Erik Skullerud as Chief Executive Officer (CEO). He will take up the position on 20 September 2021 and will be based in the company's office in Zug, Switzerland, splitting his time between Zug and Nord...
Ascendis Pharma Proposes up to $460m Public Offering of ADSs (2021-08-31)
Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to potentially create new treatments that make a meaningful difference in patients’ lives, today announced that it has commenced an underwritten publ...
Vicore Pharma Appoints New CCO & VP of Business Development (2021-08-27)
Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the addition of three experienced executives to its management...
Cardior Raises €64m Series B to Advance ncRNA Therapeutics (2021-08-25)
Oversubscribed round enables late-stage clinical development of lead candidate, a micro-RNA-132 inhibitor, in heart failure and further accelerates pipeline expansion Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-b...
Nanoform & Boehringer Execute Master Services Agreement (2021-08-17)
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform’s award-winning CESS® technology can deliver to its drug development projects. ...
Atlas Antibodies AB Acquires Swiss-based Evitria SA (2021-07-28)
Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of c...
Anocca AB Raises $47m Series B Round Led by Danske Bank (2021-07-22)
Financing from renowned Nordic investors Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics for cancer, today announced the closing of a USD 47 million (SEK 400 million) Series B financing to further a...
Philip Morris to Acquire Fertin Pharma for DKK5.1b ($820m) (2021-07-01)
The acquisition advances PMI’s goal to become a majority smoke-free business by 2025 and creates growth opportunities beyond nicotine Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin Pharma A/...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)